Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
-
- Jeffrey Hrkach
- BIND Biosciences Inc., Cambridge, MA 02139, USA.
-
- Daniel Von Hoff
- TGen Clinical Research Services at Scottsdale Healthcare, Phoenix, AZ 85004, USA.
-
- Mir Mukkaram Ali
- BIND Biosciences Inc., Cambridge, MA 02139, USA.
-
- Elizaveta Andrianova
- BIND Biosciences Inc., Cambridge, MA 02139, USA.
-
- Jason Auer
- BIND Biosciences Inc., Cambridge, MA 02139, USA.
-
- Tarikh Campbell
- BIND Biosciences Inc., Cambridge, MA 02139, USA.
-
- David De Witt
- BIND Biosciences Inc., Cambridge, MA 02139, USA.
-
- Michael Figa
- BIND Biosciences Inc., Cambridge, MA 02139, USA.
-
- Maria Figueiredo
- BIND Biosciences Inc., Cambridge, MA 02139, USA.
-
- Allen Horhota
- BIND Biosciences Inc., Cambridge, MA 02139, USA.
-
- Susan Low
- BIND Biosciences Inc., Cambridge, MA 02139, USA.
-
- Kevin McDonnell
- BIND Biosciences Inc., Cambridge, MA 02139, USA.
-
- Erick Peeke
- BIND Biosciences Inc., Cambridge, MA 02139, USA.
-
- Beadle Retnarajan
- BIND Biosciences Inc., Cambridge, MA 02139, USA.
-
- Abhimanyu Sabnis
- BIND Biosciences Inc., Cambridge, MA 02139, USA.
-
- Edward Schnipper
- BIND Biosciences Inc., Cambridge, MA 02139, USA.
-
- Jeffrey J. Song
- BIND Biosciences Inc., Cambridge, MA 02139, USA.
-
- Young Ho Song
- BIND Biosciences Inc., Cambridge, MA 02139, USA.
-
- Jason Summa
- BIND Biosciences Inc., Cambridge, MA 02139, USA.
-
- Douglas Tompsett
- BIND Biosciences Inc., Cambridge, MA 02139, USA.
-
- Greg Troiano
- BIND Biosciences Inc., Cambridge, MA 02139, USA.
-
- Tina Van Geen Hoven
- BIND Biosciences Inc., Cambridge, MA 02139, USA.
-
- Jim Wright
- BIND Biosciences Inc., Cambridge, MA 02139, USA.
-
- Patricia LoRusso
- Karmanos Cancer Institute, Detroit, MI 48201, USA.
-
- Philip W. Kantoff
- Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
-
- Neil H. Bander
- Weill Cornell Medical College, New York, NY 10065, USA.
-
- Christopher Sweeney
- Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
-
- Omid C. Farokhzad
- Laboratory of Nanomedicine and Biomaterials and Department of Anesthesiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA.
-
- Robert Langer
- Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
-
- Stephen Zale
- BIND Biosciences Inc., Cambridge, MA 02139, USA.
書誌事項
- 公開日
- 2012-04-04
- DOI
-
- 10.1126/scitranslmed.3003651
- 公開者
- American Association for the Advancement of Science (AAAS)
この論文をさがす
説明
<jats:p>A targeted nanoparticle containing docetaxel displays antitumor activity in animals and differentiated pharmacological properties in patients with advanced solid tumors.</jats:p>
収録刊行物
-
- Science Translational Medicine
-
Science Translational Medicine 4 (128), 128ra39-, 2012-04-04
American Association for the Advancement of Science (AAAS)
